Answers are grounded in this paper and cite their sources.
BACKGROUND AND AIMS: Smoking is a leading cause of preventable death and illness. Genetically-informed precision interventions are feasible, but whether genetic risk for persistent smoking can be captured by high-risk single nucleotide polymorphisms (SNPs) or requires comprehensive assessment using whole-genome polygenic risk scores (PRS) is unknown. This study compared discriminatory performance of a baseline model for long-term persistent smoking based on phenotypic predictors with models that (1) integrate phenotypic predictors with three well-characterized SNPs and (2) incorporate phenotypic predictors and PRS for smoking cessation. DESIGN: Data were from the Nurse's Health Study (NHS) and NHS II, two all-female, prospective cohorts that collected data every 2 years. Two independent data sources were used from baseline (1976 for NHS and 1989 for NHS II) and up to 2014 for NHS and 2015 for NHS II. SETTING: Population-based, longitudinal cohort studies of nurses from 17 states in the United States. PARTICIPANTS: Female, baseline ever-smokers of European ancestry with whole-genome genetic data (NHS: n = 10 017; NHS II: n = 2793). MEASUREMENTS: ). Additional genetic predictors for persistent smoking were estimated by (1) three well-characterized risk SNPs for smoking (CHRNA5 rs16969968, CYP2A6 rs56113850, DRD2/ANKK1 rs1800497) and (2) PRS. The primary outcome of the study was improvement in predictive performance as measured by the area under the receiver operating characteristics curve (AUC) between baseline models for long-term persistent smoking and models adding genetic risk with (1) risk SNPs and (2) PRS. RESULTS: Within NHS, the baseline model showed moderate predictive performance for persistent smoking with an AUC of 0.674. Adding SNPs showed similar performance (AUC = 0.675), whereas adding PRS statistically significantly improved discriminatory performance, raising the AUC to 0.730, a 5.7% [95% confidence interval (CI) = 5.4%-5.9%] improvement in prediction (AUC) over baseline models. Results were replicated in NHS II, where baseline and SNP models performed moderately with AUCs of 0.671 and 0.677, and adding PRS increased the AUC to 0.735, representing a 6.4% (95% CI = 5.9%-6.8%) improvement in prediction over baseline models. SUMMARY: Among females of European ancestry, polygenic risk scores appear to enhance identification of individuals at high risk for long-term, persistent smoking compared with single well-known risk variants and phenotypic predictors. Combining genetic and phenotypic factors can improve risk stratification and precision intervention guidance for long-term smoking abstinence management.
No takes yet. Share an insight, caveat, or question.
Jones et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: